Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Richard_Saynor
|
| gptkbp:country |
gptkb:Switzerland
|
| gptkbp:foundedIn |
1886
|
| gptkbp:founder |
gptkb:Alfred_Kern
gptkb:Edouard_Sandoz |
| gptkbp:headquartersLocation |
gptkb:Basel,_Switzerland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sandoz Ltd.
|
| gptkbp:industry |
Pharmaceuticals
Generics Biosimilars |
| gptkbp:legalForm |
Aktiengesellschaft (AG)
|
| gptkbp:mergedInto |
gptkb:Novartis
1996 |
| gptkbp:notableEmployee |
gptkb:Albert_Hofmann
|
| gptkbp:notableEvent |
Discovery of LSD by Albert Hofmann in 1938
|
| gptkbp:notableProduct |
gptkb:Penicillin
LSD Generic medicines Biosimilar medicines |
| gptkbp:numberOfEmployees |
~22,000 (2023)
|
| gptkbp:parentCompany |
gptkb:Novartis
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:servesArea |
Worldwide
|
| gptkbp:spinOff |
Novartis (2023)
|
| gptkbp:stockExchange |
gptkb:SIX_Swiss_Exchange
|
| gptkbp:stockSymbol |
gptkb:SDZ
|
| gptkbp:website |
https://www.sandoz.com/
|
| gptkbp:bfsParent |
gptkb:US_Patent_3991359
|
| gptkbp:bfsLayer |
7
|